Trials / Conditions / HER2-expressing Cancers
HER2-expressing Cancers
3 registered clinical trials studyying HER2-expressing Cancers.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer NCT05027139 | Jazz Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers NCT03821233 | Zymeworks BC Inc. | Phase 1 |
| Completed | Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers NCT02892123 | Jazz Pharmaceuticals | Phase 1 |